NASDAQ Biotech Index Nearing Resistance: Is It Time For A Breakout? (Video)

Biotech was a silent but pronounced leader for much of the bull market, with the NASDAQ Biotech Index climbing nearly fourfold since its March, 2009 low. In recent weeks, however, it’s been underperforming, with Celgene’s (CELG) earnings miss responsible for much of the index’s weakness. Now, though, it looks like biotech is once again gaining steam…Please subcribe to read more.